As the biopharma world predominantly invests in late-stage assets, Eli Lilly is prioritizing early science with the opening ...

Philadelphia is joining the San Francisco Bay area, Boston, and San Diego as a host of a Lilly Gateway Labs biotech incubator ...

Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, developed 2300 Market to be the most comprehensive R&D ecosystem in the Philadelphia market. Legend Biotech selected the ...

Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.

Pharmaceutical giant Eli Lilly and Co. is bringing its next Gateway Labs to Philadelphia. Here's where and why.

Eli Lilly & Co. is bringing a pharmaceutical startup incubator to 2300 Market St. MCB Science + Health has finished the ...

INDIANAPOLIS, Sept. 26, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the official opening of its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its ...

With a strong profitability outlook, Eli Lilly and Company (NYSE:LLY) secures a spot on our list of the 14 Stocks That Will Double in the Next 5 Years. On September 26, 2025, Eli Lilly and Company ...

To provide access to dedicated, fully equipped wet lab facilities and strategic scientific engagement.

Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing ...

Eli Lilly (LLY) announced plans to open a new Lilly Gateway Labs site in Philadelphia. The new Gateway Labs site will occupy 44,000 square feet of ...